Authors:
Cingolani, GM
Di Stefano, A
Napolitani, F
Mosciatti, B
Giorgioni, G
Cinone, N
Brunetti, L
Luisi, G
Michelotto, B
Orlando, G
Costa, B
Lucacchini, A
Martini, C
Claudi, F
Citation: Gm. Cingolani et al., Synthesis and preliminary pharmacological evaluation of 5-hydroxy- and 5,6-dihydroxy-1,2,3,7,12,12a-hexahydrobenzo [5,6]cyclohepta[1,2,3-ij]isoquinoline derivatives as dopamine receptor ligands, BIO MED CH, 9(6), 2001, pp. 1447-1458
Citation: G. Giorgioni, New evidence on the output-inflation trade-off from developing economies: the case of the CFA Franc zone, APPL ECON, 33(8), 2001, pp. 1077-1082
Authors:
Cingolani, GM
Di Stefano, A
Mosciatti, B
Napolitani, F
Giorgioni, G
Ricciutelli, M
Claudi, F
Citation: Gm. Cingolani et al., Synthesis of L-(+)-3-(3-hydroxy-4-pivaloyloxybenzyl)-2,5-diketomorpholine as potential prodrug of L-dopa, BIOORG MED, 10(12), 2000, pp. 1385-1388
Authors:
Claudi, F
Di Stefano, A
Napolitani, F
Cingolani, GM
Giorgioni, G
Fontenla, JA
Montenegro, GY
Rivas, ME
Rosa, E
Michelotto, B
Orlando, G
Brunetti, L
Citation: F. Claudi et al., Binding and preliminary evaluation of 5-hydroxy- and 10-hydroxy-2,3,12,12a-tetrahydro-1H-[1]benzoxepino[2,3,4-ij]isoquinolines as dopamine receptor ligands, J MED CHEM, 43(4), 2000, pp. 599-608
Authors:
Claudi, F
Scoccia, L
Giorgioni, G
Accorroni, B
Marucci, G
Gessi, S
Siniscalchi, A
Borea, PA
Citation: F. Claudi et al., 4-(4-fluorobenzoyl)-1-[2-(4-iodo-2,5-dimethoxyphenyl)ethyl]piperidine and its derivatives: synthesis and affinity at 5-HT2A, 5-HT2B and 5-HT2C serotonin receptors, EUR J MED C, 34(10), 1999, pp. 843-852